Fil LTD Tempest Therapeutics, Inc. Transaction History
Fil LTD
- $95.2 Billion
- Q1 2024
A detailed history of Fil LTD transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Fil LTD holds 129,579 shares of TPST stock, worth $261,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,579
Previous 129,579
-0.0%
Holding current value
$261,749
Previous $570,000
11.23%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TPST
# of Institutions
34Shares Held
1.43MCall Options Held
161KPut Options Held
78K-
Black Rock Inc. New York, NY508KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$355,9090.0% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$266,8070.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$213,3120.05% of portfolio
-
Bank Of America Corp Charlotte, NC43KShares$86,9180.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $21M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...